TAVI: 60 Second Insights
Published: 28 March 2018
-
Views:
394 -
Likes:
7
-
Views:
394 -
Likes:
7
-
Up Next
-
1m 2sPart 4 | Session 2 Francesco Maisano
-
20sPart 5 | Session 1 Nicolas Van Mieghem
-
1m 5sPart 5 | Session 2 Francesco Maisano
-
37sPart 6 | Session 1 Nicolas Van Mieghem
-
57sPart 6 | Session 2 Francesco Maisano
-
29sPart 7 | Session 1 Nicolas Van Mieghem
-
1mPart 7 | Session 2 Francesco Maisano
-
18sPart 8 | Session 1 Nicolas Van Mieghem
-
1m 10sPart 8 | Session 2 Francesco Maisano
-
36sPart 1 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
1m 2sPart 1 | Session 2 Francesco Maisano Francesco Maisano
-
28sPart 2 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
55sPart 2 | Session 2 Francesco Maisano Francesco Maisano
-
31sPart 3 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
1m 8sPart 3 | Session 2 Francesco Maisano Francesco Maisano
Overview
A short series of 60-second insight videos on TAVI.
More from this programme
Part 1
Do you think it is necessary to perform coronary revascularisation pre-TAVR? Do you use FFR/iFR decision-making?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 2
Are we ready to be doing TAVR in low risk patients?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 3
Which patients are you performing TAVR in now (High/Medium risk)?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 4
Which is your preferred valve, and why?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 5
How would you recommend someone start a TAVR program?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 6
What is the most important clinical trial data and why?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 7
What is the biggest innovation in TAVR over the past 12-24 months?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Part 8
What proportion of your patients have a TAVR rather than and surgical AVR?
2 sessions | |
Nicolas Van Mieghem | Watch now |
Francesco Maisano | Watch now |
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…